Application 090781
- Type
- ANDA
- Sponsor
- GLENMARK GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | TABLET;ORAL | 0.125MG | No | No |
| 002 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | TABLET;ORAL | 0.25MG | No | No |
| 003 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | TABLET;ORAL | 0.5MG | No | No |
| 004 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | TABLET;ORAL | 1MG | No | No |
| 005 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | TABLET;ORAL | 1.5MG | No | No |
| 006 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | TABLET;ORAL | 0.75MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090781-001 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090781-002 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | RS | 2010-10-08 |
| A090781-003 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090781-004 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090781-005 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090781-006 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2015-09-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090781-001 | AB |
| A090781-002 | AB |
| A090781-003 | AB |
| A090781-004 | AB |
| A090781-005 | AB |
| A090781-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090781-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090781-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | RS | 2010-10-08 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090781-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090781-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090781-006 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2015-09-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090781-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-006 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pramipexole dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | 44c336d2-01d1-4f13-bad9-549cdc3505ec | 2025-12-30 | Warnings, Adverse reactions | 090781 ANDA090781 68462-332 68462-330 68462-334 68462-331 68462-333 68462-627 |
| Pramipexole dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 5e6f2187-a5cc-481e-b0a1-d38d3f92e822 | 2024-10-09 | Warnings, Adverse reactions | 090781 ANDA090781 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-2190 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | A-S Medication Solutions | ANDA | Current |
| 50090-2190 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | A-S Medication Solutions | ANDA | Current |
| 50090-2190 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | A-S Medication Solutions | ANDA | Current |
| 50090-2217 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | A-S Medication Solutions | ANDA | Current |
| 68462-330 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-330 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-330 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-330 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-331 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-331 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-331 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-331 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-332 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-332 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-332 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-332 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-333 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-333 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-333 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-333 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-334 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-334 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-334 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-334 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-627 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-627 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-627 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-627 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 70934-596 | Pramipexole dihydrochloride | Pramipexole dihydrochloride | Denton Pharma, Inc. dba Northwind Pharmaceuticals | ANDA | Current |